• Foghorn Therapeutics to Participate in Two Upcoming Virtual Investor Conferences

    Source: Nasdaq GlobeNewswire / 01 Sep 2021 15:05:00   America/Chicago

    CAMBRIDGE, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (Nasdaq: FHTX), a clinical stage biotechnology company pioneering a new class of medicines that modulate gene expression through selectively targeting the chromatin regulatory system, today announced that Foghorn management will participate in two upcoming virtual investor conferences.

    Events:

    Morgan Stanley Virtual Annual Global Healthcare Conference
    Format: Fireside Chat and investor 1x1 meetings
    Thursday, September 9, 2021
    11:45am ET
    Please find a link to the presentation here. A replay will be available for 90 days.

    H.C. Wainwright 23rd Annual Global Investment Conference
    Format: Presentation and investor 1x1 meetings
    Monday, September 13, 2021
    All company presentations will be available on-demand beginning at 7:00am ET
    Please find a link to the presentation here.

    A webcast of both presentations can also be accessed under “Events & Presentations” in the Investors section of the Company’s website, www.foghorntx.com

    About Foghorn Therapeutics

    Foghorn® Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control® platform, Foghorn is systematically studying, identifying and validating potential drug targets within the chromatin regulatory system. The company is developing multiple product candidates in oncology.

    Media Contact:

    Fanny Cavalié, Foghorn Therapeutics Inc.
    fcavalie@foghorntx.com 

    Gregory Kelley, Ogilvy
    gregory.kelley@ogilvy.com 

    Investor Relations Contact:

    Ben Strain, Foghorn Therapeutics Inc.
    bstrain@foghorntx.com 

    Hans Vitzthum, LifeSci Advisors
    617-430-7578
    hans@lifesciadvisors.com 


    Primary Logo

Share on,